Newspapers and magazines at the RMH Parkville
You can purchase newspapers and magazines from the retail shop.
https://www.thermh.org.au/locations/rmh-parkville/visiting-the-rmh-parkville/newspapers-magazines-at-the-rmh-parkvilleThe Older Persons Care Hub provides short-term assessment and care planning in your home, so you can avoid unnecessary trips to the Emergency Department or hospital.
https://www.thermh.org.au/your-care/ongoing-care/older-persons-care-hubBitopertin as a treatment for erythropoietic protoporphyria Research study
Research project to measure how safe and effective bitopertin (DISC-1459) is in treating participants with erythropoietic protoporphyria.
https://www.thermh.org.au/research/clinical-trials-research-studies/bitopertin-as-a-treatment-for-erythropoietic-protoporphyriaOur Health Hub patient portal is a secure mobile and web application that allows you to see and manage information about your care at the Royal Melbourne Hospital and other Parkville health services.
https://www.thermh.org.au/your-care/hospital-care/your-hospital-stay/your-medical-records/health-hub-portalThe Home Dialysis service is based at the RMH Royal Park and supports both peritoneal dialysis and home haemodialysis.
https://www.thermh.org.au/services/kidney-care/learn-about/home-dialysisRECHARGE 1: Assessing study treatment in adult patients with moderate to severe hidradenitis suppurativa (HS) Research study
Phase 3 study to assess efficacy, safety and tolerability of a study treatment in adult patients with moderate to severe hidradenitis suppurativa (HS).
https://www.thermh.org.au/research/clinical-trials-research-studies/remibrutinib-in-patients-with-moderate-to-severe-hidradenitis-suppurativaNew treatment for moderate-to-severe plaque psoriasis Research study
Treatments that are highly selective in inhibiting the body's immune response have the potential to increase quality of life for people with plaque psoriasis.
https://www.thermh.org.au/research/clinical-trials-research-studies/evaluating-the-efficacy-safety-and-tolerability-of-a-new-treatment-for-people-with-moderate-to-severe-plaque-psoriasisRitlecitinib in adults with non-segmental vitiligo Research study
This trial is investigating a medication for treating people living with non-segmental vitiligo.
https://www.thermh.org.au/research/clinical-trials-research-studies/new-treatment-for-vitiligoPrurigo Nodularis trial Research study
The Prurigo Nodularis trial aims to assess the safety and effectiveness of a treatment to assist in reducing symptoms for people living with this condition
https://www.thermh.org.au/research/clinical-trials-research-studies/prurigo-nodularis-trialCombination treatment for locally advanced or metastatic ER-positive breast cancer Research study
A phase II, multicentre, randomised study to compare the efficacy of venetoclax plus fulvestrant as a combination treatment for locally advanced or metastatic ER-positive breast cancer.
https://www.thermh.org.au/research/clinical-trials-research-studies/combination-treatment-for-locally-advanced-or-metastatic-er-positive-breast-cancerHealth Hub leading to improved patient health outcomes News article
A survey conducted earlier this year of Parkville precinct patients and carers found technology has improved their overall health.
https://www.thermh.org.au/news/health-hub-leading-to-improved-patient-health-outcomesWe welcome visitors. They improve a patient’s recovery and the communication between patients, families and staff.
https://www.thermh.org.au/your-care/hospital-care/what-you-need-to-know-up-front/visitors-visiting-hoursParking near the RMH Parkville
Limited parking is available in the RMH Parkville car park. The car park is open 7 days a week, 6am to 9pm. If you are a regular visitor, a reduced parking rate is available.
https://www.thermh.org.au/locations/rmh-parkville/getting-to-the-rmh-parkville/parking-near-the-rmh-parkvilleNew treatment study for people with lupus Research study
This early-phase study is testing a new treatment for adults with moderate to severe lupus (SLE). The new treatment is a type of antibody designed to help the immune system remove certain B cells that play a role in lupus.
https://www.thermh.org.au/research/clinical-trials-research-studies/new-treatment-study-for-people-with-lupsThe Clinical Trials Centre (CTC) is a dedicated purpose-built space for conducting clinical trials. All clinical trial visits at the Royal Melbourne Hospital take place in this space.
https://www.thermh.org.au/research/about-clinical-trials/our-clinical-trials-centrePossible treatment for Parkinson’s disease Research study
Cerevel Therapeutics has begun a study of an experimental drug called CVL-751 as a possible treatment for people with Parkinson’s disease.
https://www.thermh.org.au/research/clinical-trials-research-studies/possible-treatment-parkinsons-diseaseANAVEX®2-73 for mild cognitive impairment or early Alzheimer’s disease Research study
A clinical trial that aims to assess the safety and efficacy of a new drug (ANAVEX®2-73) for the treatment of early Alzheimer’s disease.
https://www.thermh.org.au/research/clinical-trials-research-studies/anavex-2-73-mild-cognitive-impairment-or-early-alzheimers-diseaseUnderstanding antigen triggers in psoriasis Research study
A non-interventional study to investigate triggers in psoriasis.
https://www.thermh.org.au/research/clinical-trials-research-studies/understanding-antigen-triggers-in-psoriasisYou have the right to access information about you and your medical records held by the Royal Melbourne Hospital.
https://www.thermh.org.au/your-care/hospital-care/your-hospital-stay/your-medical-recordsFind out about our amenities at the RMH Parkville to plan your visit.
https://www.thermh.org.au/locations/rmh-parkville/visiting-the-rmh-parkville